[RPRX] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[RPRX] Royalty Pharma plc
Announcement Date
15-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -380.11%
YoY- -7,819.75%
Quarter Report
RPRX's Result
RPRX's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 536,313 538,202 683,971 565,748 573,463 535,955 562,049 -3.07%
PBT 122,077 351,336 509,089 -610,030 220,414 491,597 128,083 -3.14%
Tax 49,963 123,711 168,334 139 2,582 187,093 167,957 -55.40%
NP 72,114 227,625 340,755 -610,169 217,832 304,504 -39,874 -
Tax Rate -40.93% -35.21% -33.07% - -1.17% -38.06% -131.13% -
Total Cost 464,199 310,577 343,216 1,175,917 355,631 231,451 601,923 -15.89%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin 13.45 42.29 49.82 -107.85 37.99 56.82 -7.09 -
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS 0.16 0.51 0.76 -1.38 0.36 0.50 -0.07 -
EPS Diluted 0.16 0.50 0.76 -1.38 0.36 0.50 -0.07 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.